Skip to main content

Members


Jeremy Barr
Monash University, School of Biological Sciences
Interests: Phage-Eukaryotes, Cell Biology, Acinetobacter baumannii phage therapy
jeremy.barr@monash.edu

Scott Beatson
The University of Queensland, School of Chemistry & Molecular Biosciences
Interests: Molecular pathogenomics, genomics to investigate multidrug resistant bacteria
s.beatson@uq.edu

Mihnea Bostina
University of Otago, Health Sciences
Interests: Structural biology, viral pathogenesis, molecular virology
mihnea.bostina@otago.ac.nz

Kim Chan
The University of Sydney, School of Pharmacy
Interests: Respiratory drug delivery, aerosol formulation, inhaled phage therapy, respiratory infections
kim.chan@sydney.edu.au

 Mark Chan
Royal Melbourne Hospital, Department of Microbiology
Interests: Phage discovery, Phage diagnostics and therapeutics, medical microbiology, quality manufacturing, difficult-to-treat infections
mark.chan3@mh.org.au

Barbara Chang
The University of Western Australia, Pathology and Laboratory Medicine
Interests: Phage therapy, quorum sensing, Aeromonas hydrophila, Clostridium difficile, Moraxella catarrhalis
barabara.chang@uwa.edu.au

Aleksandra Petrovic Fabijan
The Westmead Institute, Centre for Infectious Diseases and Microbiology
Interests: Phage therapy, sepsis, Staphylococcus aureus, clinical studies
aleksandra.petrovicfabijan@sydney.edu.au

Peter Fineran
University of Otago, Microbiology & Immunology
Interests: Phage resistance mechanisms, CRISPR-Cas, toxin-antitoxin
peter.fineran@otago.ac.nz

Lucy Furfaro
The University of Western Australia, School of Women's and Infant's Health
Interests: Microbiology, phage therapy, Group B Streptococcus
lucy.furfaro@uwa.edu.au

James Harnett
Fonterra, Inc.
Interests: Dairy, cheese, food spoilage

Heather Hendrickson
University of New Zealand, Massey University
Interests: Bacterial evolution, phage discovery, DNA replication termination
h.hendrickson@massey.ac.nz

 Chris Huang
Phagelux, Inc.
Interests: Phages, lysins, delivery technologies for antibacterial solutions

Phil Hugneholtz
The University of Queensland, Australia Centre for Ecogenomics
Interests: Microbial ecology and evolution
p.hugenholtz@uq.edu

John Iredell
The University of Sydney, School of Medicine
Interests: Infectious diseases, antibiotic resistance, phage therapy
jonathan.iredell@sydney.edu.au

Paul Jaschke
Macquarie University, Department of Molecular Sciences
Interests: Synthetic virus genomes, biosynthesis, engineered genetic systems
paul.jaschke@mq.edu.au

Charlene Kahler
The University of Western Australia, Infection and Immunity
Interests: Bacterial pathogenesis, septic shock,  epidemiology
charlene.kahler@uwa.edu.au

Ipek Kurtboke
University of the Sunshine Coast
Interests: Antibiotic production, phage genome annotation and taxonomy, phage agriculture
ikurtbok@usc.edu.au

 Jian Li
Monash University, Biomedicine Discovery Institute
Interests: Antimicrobial resistance, pharmacology, Gram-negative multidrug-resistant pathogens
jian.li@monash.edu

Trevor Lithgow
Monash University, Medicine, Nursing and Health Sciences
Interests: Molecular and cellular biology, outer membrane proteins, antibiotic resistance, structural biology
trevor.lithgow@monash.edu

Mike McDonald
Monash University, School of Biological Sciences
Interests: Experimental evolution, horizontal gene transfer, phage ecology and evolution
mike.mcdonald@monash.edu

Sandra Morales
AmpliPhi Biosciences Corporation
Interests: Phage therapy, industrial experience for phage preparation, applied molecular biotechnology

Diane Ouwerkerk
Department of Agriculture and Fisheries, Queensland
Interests: Ruminant biology
diane.ouwerkerk@daf.qld.gov.au

Leigh Owens
James Cook University, College of Public Health, Medical and Vet Sciences
Interests: Bacteriophage biology of Vibrio harveyi, RNA interference
leigh.owens@jcu.edu.au

Matt Payne
The University of Western Australia, Obstetrics and Gynaecology
Interests: Phage therapy, prevention of pre-term birth, Ureaplasma spp., Mycopasma hominis, animal models
matthew.payne@uwa.edu.au

Anton Peleg
The Alfred Hospital and Monash University, Department of Infectious Diseases
Interests: Clinical to basic research, hospital-acquired infections, antimicrobial resistance, Acinetobacter baumannii, Staphylococcus aureus and Candida albicans.
anton.peleg@monash.edu

 Steve Petrovski
La Trobe University, College of Science, Health and Engineering
Interests: Phage biology, Actinophages, lysogeny, plasmid biology, wastewater biology
steve.petrovski@latrobe.edu.au

 Nico Petty
University of Technology Sydney, ithree institute
Interests: evolution and spread of clinical pathogens, phage therapy, comparative genomics
nicola.petty@uts.edu.au

Jasna Rakonjac
University of New Zealand, Massey University
Interests: Filamentous phage, phage display, bacterial secretion
j.rakonjac@massey.ac.nz

Keith Shearwin
University of Adelaide, Molecular and Cellular Biology
Interests: Synthetic biology, biochemistry, mathematical modelling, lambda phage biology
keith.shearwin@adelaide.edu.au

 Keith Potent
Monash University, Translation Research
Interests: Clinical trials, phage engineering, cancer biology
keith.potent@monash.edu.au

 Peter Speck
Flinders University, College of Science and Engineering
Interests: Phage therapy, rhinosinusitis of Staphylococcus aureus, virology
peter.speck@flinders.edu.au

Stephanie Trend
Telethon Kids Institute
Interests: Phage therapy, immunophage synergy, cystic fibrosis infections, human milk microbiome, infant microbiome and immune development
Stephanie.Trend@telethonkids.org.au

Joe Tucci
Clinical Pharmacist, La Trobe Institute for Molecular Sciences
Interests: Phage therapy, pharmacogenomics
j.tucci@latrobe.edu.au

Carola Venturini
The University of Sydney, School of Medicine
Interests: Mobile genetic elements, phage therapy, antibiotic resistance
carola.venturini@sydney.edu.au

Karen Weynberg
The University of Queensland, School of Chemistry and Molecular Biosciences
Interests: Synthetic biology, phage therapy, virology, bacterial biofilms
k.weynberg@uq.edu.au

Peter-John Wormald
The University of Adelaide, Faculty of Health and Medical Sciences
Interests: Ear, nose and throat surgeon, translational health, phage therapy of chronic rhinosinusitis
peterj.wormald@adelaide.edu.au


Comments

Post a Comment

Popular posts from this blog

Viruses of Microbes 2024 - Cairns, Australia!

 Hi Everyone, We are excited to announce that the Viruses of Microbes 2024 meeting will be held in Cairns, Australia! Being situated on the shores of the Great Barrier Reef and surrounded by the oldest rainforest on Earth, Cairns will host a truly unique VoM experience. This also marks the first time that the VoM conference series will take place outside of Europe and will be an excellent opportunity to promote Australian phage research. The theme for VoM 2024 will be 'Expanding our viral frontiers', which references both the expansion of the VoM conference series to Australia and a focus on the next frontiers for viruses of microbes research.  Our organising committee so far is led by Dr. Jeremy J. Barr as conference convenor (Monash University), along with A/Prof. Ruby CY Lin (Westmead Institute), Dr. Lucy Furfaro (University of Western Australia), Dr. Karen Weynberg (The University of Queensland), Dr. Paul Jaschke (Macquire University) and Prof. Jon Iredell (Westmead Institu
Post a Comment
Read more

Phage postdoctoral position available at UQ

  A collaborative phage research team led by Prof. Phil Hugenholtz, Dr. Karen Weynberg and Dr. Seweryn Bialasiewicz at the Australian Centre for Ecogenomics, The University of Queensland, are seeking to appoint a post-doctoral researcher with phage research expertise. The position is available of a 6-month full-time basis or a 1-year part-time basis. Further details are available by contacting Dr. Karen Weynberh at k.weynberg@uq.edu.au
Post a Comment
Read more

New home for Bacteriophage SIG

  Hi everyone, I just wanted to make a quick post to update you all on a few new SIG goals and directions for '21 and '22. We will be transitioning away from our SIG blog site ( Bacteriophage Biology & Therapeutics SIG ) and moving onto the ASM communities platform ( Login - Australian Society for Microbiology ). I would like to encourage everyone to sign up for an account on ASM communities, to join the Bacteriophage community, and select receive notifications for any posts made. We will continue to post updates on our blog site in the meanwhile, but the long term plan is to transition our SIG communication to ASM communities and quarterly email updates. In other news, we are planning some PhD and ECR focused Bacteriophage SIG events for '22. We will have more news in the coming months, but if you could let any interested students and phage researchers know about this that would be greatly appreciated. Cheers,
Post a Comment
Read more